Pfizer acquired the Eucrisa (crisaborole) when it bought its developer, Anacor in May this year for $5.2 billion. Skip to main content Friday 20 December 2024 ...

Topical Non-Steroidal Anti-Inflammatories (Medication) Dermatologists may recommend non-steroidal options—such as topical ...